July 28, 2014 9:31 AM ET


Company Overview of Thallion Pharmaceuticals, Inc.

Executive Profile

Allan Mandelzys Ph.D., MBA.

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Allan Mandelzys, Ph.D., MBA served as Consultant at Thallion Pharmaceuticals, Inc. from July 01, 2013 to September 30, 2013 and Chief Executive Officer from January 11, 2010 to July 01, 2013. Dr. Mandelzys served as an Executive Vice President of Licensing & Corporate Development of Thallion Pharmaceuticals, Inc. from April 25, 2007 to January 11, 2010. He has extensive experience in the domains of drug licensing and partnering. He served as Vice President of Business ...

Corporate Headquarters

1375 TransCanada Highway
Dorval, Quebec H9P 2W8


Phone: 514-940-3600
Fax: 514-940-3620

Board Members Memberships



University of Toronto
McGill University
McGill University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Thallion Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.